Sage Therapeutics (SG7.F) Q2 2024 Earnings

25AprConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-1.68
-1.63
-1.59
-1.54

Details

Expected EPS
-1.53969957042
Actual EPS
-1.6808040000000002
Surprise EPS
-0.14
Surprise Percent
+9.16%

Description

Sage Therapeutics (SG7.F) has reported earnings of -1.6808040000000002 per share for Q2 2024.

0 Comments

Share your thoughts